Dynatronics Corporation
DYNTQ Healthcare Medical Devices
Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024. In the quarter to September 2025, revenue fell 7.61%, EPS grew 66.7% and free cash flow fell 193.0%, each against the same quarter a year earlier.
Follow DYNTQ
Dynatronics Corporation (DYNTQ) EV/Sales
As of 15 October 2026, Dynatronics Corporation (DYNTQ) trades at a EV/Sales of 0.1×. Over the past ten years it has ranged from 0.1× (October 2026) to 0.6× (May 2018) — the current reading is the lowest in ten years. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.1× | 6.38% |
| FY2024 | 0.1× | (13.57%) |
| FY2023 | 0.1× | (51.00%) |
| FY2022 | 0.3× | (10.26%) |
| FY2021 | 0.3× | 16.95% |
| FY2020 | 0.3× | (30.64%) |
| FY2019 | 0.4× | (12.13%) |
| FY2018 | 0.4× | 5.94% |
| FY2017 | 0.4× | 11.24% |
| FY2016 | 0.4× | 1.99% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2025 | 0.1× | 12.81% |
| Jun 2025 | 0.1× | (5.15%) |
| Mar 2025 | 0.1× | 6.47% |
| Dec 2024 | 0.1× | 3.74% |
| 39 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| NUWE Nuwellis, Inc. compare | 0.0× |
| FEED ENvue Medical, Inc. compare | 0.1× |
| DYNTQ Dynatronics Corporation | 0.1× |
| DHAI DIH Holding US, Inc. compare | 0.1× |
| SSKN Strata Skin Sciences, Inc. compare | 0.7× |
| THMO ThermoGenesis Holdings, Inc. compare | 0.8× |
| AFIB Acutus Medical, Inc. compare | 0.9× |
| VJET Flyte Aviation, Inc. compare | 2.1× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)